Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Neurochem Int ; 112: 1-4, 2018 01.
Article in English | MEDLINE | ID: mdl-29080803

ABSTRACT

We report a significant reduction in plasma methionine concentrations in relapse remitting multiple sclerosis (MS) patients compared to controls. In vivo studies demonstrate that changes in peripheral methionine levels in mice can regulate histone H3 methylation and expression of DNA methyltransferase 3A (DNMT3A) centrally, in the cerebral cortex. Therefore, we propose that decreases in circulating methionine represent one of the earliest manifestations of dysregulated methionine metabolism in MS with potential impacts on both histone H3 and DNA methylation in the central nervous system.


Subject(s)
Cerebral Cortex/metabolism , Methionine/metabolism , Multiple Sclerosis, Relapsing-Remitting/metabolism , Adult , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/pathology , DNA Methyltransferase 3A , Female , Humans , Injections, Subcutaneous , Male , Methionine/administration & dosage , Mice , Mice, Inbred C57BL , Middle Aged , Multiple Sclerosis, Relapsing-Remitting/pathology
2.
Hum Mol Genet ; 22(18): 3705-19, 2013 Sep 15.
Article in English | MEDLINE | ID: mdl-23704330

ABSTRACT

Genetic variants in one-carbon folate metabolism have been identified as risk factors for disease because they may impair the production or use of one-carbon folates required for nucleotide synthesis and methylation. p.R653Q (1958G>A) is a single-nucleotide polymorphism (SNP) in the 10-formyltetrahydrofolate (formylTHF) synthetase domain of the trifunctional enzyme MTHFD1; this domain produces the formylTHF which is required for the de novo synthesis of purines. Approximately 20% of Caucasians are homozygous for the Q allele. MTHFD1 p.R653Q has been proposed as a risk factor for neural tube defects (NTDs), congenital heart defects (CHDs) and pregnancy losses. We have generated a novel mouse model in which the MTHFD1 synthetase activity is inactivated without affecting protein expression or the other activities of this enzyme. Complete loss of synthetase activity (Mthfd1S(-/-)) is incompatible with life; embryos die shortly after 10.5 days gestation, and are developmentally delayed or abnormal. The proportion of 10-formylTHF in the plasma and liver of Mthfd1S(+/-) mice is reduced (P < 0.05), and de novo purine synthesis is impaired in Mthfd1S(+/-) mouse embryonic fibroblasts (MEFs, P < 0.005). Female Mthfd1S(+/-) mice had decreased neutrophil counts (P < 0.05) during pregnancy and increased incidence of developmental defects in embryos (P = 0.052). These findings suggest that synthetase deficiency may lead to pregnancy complications through decreased purine synthesis and reduced cellular proliferation. Additional investigation of the impact of synthetase polymorphisms on human pregnancy is warranted.


Subject(s)
Aminohydrolases/genetics , Aminohydrolases/metabolism , Embryonic Development/genetics , Formate-Tetrahydrofolate Ligase/genetics , Methylenetetrahydrofolate Dehydrogenase (NADP)/genetics , Methylenetetrahydrofolate Dehydrogenase (NADP)/metabolism , Multienzyme Complexes/genetics , Multienzyme Complexes/metabolism , Pregnancy Complications/genetics , Purines/biosynthesis , Aminohydrolases/deficiency , Animals , Cell Proliferation , Cells, Cultured , Choline/metabolism , Congenital Abnormalities/genetics , Embryo Loss , Female , Folic Acid/metabolism , Formate-Tetrahydrofolate Ligase/deficiency , Formate-Tetrahydrofolate Ligase/metabolism , Gene Knock-In Techniques , Genetic Variation , Humans , Leucovorin/analogs & derivatives , Leucovorin/chemistry , Leukocyte Count , Male , Methionine/metabolism , Methylenetetrahydrofolate Dehydrogenase (NADP)/deficiency , Methylenetetrahydrofolate Reductase (NADPH2)/metabolism , Mice , Mice, Inbred C57BL , Models, Animal , Multienzyme Complexes/deficiency , Multifunctional Enzymes/genetics , Multifunctional Enzymes/metabolism , Mutagenesis, Site-Directed , Polymorphism, Single Nucleotide , Pregnancy , Pregnancy Complications/metabolism
3.
Geobiology ; 7(3): 295-307, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19476504

ABSTRACT

Authigenic phosphatic laminites enclosed in phosphorite crusts from the shelf off Peru (10 degrees 01' S and 10 degrees 24' S) consist of carbonate fluorapatite layers, which contain abundant sulfide minerals including pyrite (FeS(2)) and sphalerite (ZnS). Low delta(34)S(pyrite) values (average -28.8 per thousand) agree with bacterial sulfate reduction and subsequent pyrite formation. Stable sulfur isotopic compositions of sulfate bound in carbonate fluorapatite are lower than that of sulfate from ambient sea water, suggesting bacterial reoxidation of sulfide by sulfide-oxidizing bacteria. The release of phosphorus and subsequent formation of the autochthonous phosphatic laminites are apparently caused by the activity of sulfate-reducing bacteria and associated sulfide-oxidizing bacteria. Following an extraction-phosphorite dissolution-extraction procedure, molecular fossils of sulfate-reducing bacteria (mono-O-alkyl glycerol ethers, di-O-alkyl glycerol ethers, as well as the short-chain branched fatty acids i/ai-C(15:0), i/ai-C(17:0) and 10MeC(16:0)) are found to be among the most abundant compounds. The fact that these molecular fossils of sulfate-reducing bacteria are distinctly more abundant after dissolution of the phosphatic laminite reveals that the lipids are tightly bound to the mineral lattice of carbonate fluorapatite. Moreover, compared with the autochthonous laminite, molecular fossils of sulfate-reducing bacteria are: (1) significantly less abundant and (2) not as tightly bound to the mineral lattice in the other, allochthonous facies of the Peruvian crusts consisting of phosphatic coated grains. These observations confirm the importance of sulfate-reducing bacteria in the formation of the phosphatic laminite. Model calculations highlight that organic matter degradation by sulfate-reducing bacteria has the potential to liberate sufficient phosphorus for phosphogenesis.


Subject(s)
Bacteria/metabolism , Geologic Sediments/chemistry , Geologic Sediments/microbiology , Phosphates/metabolism , Fossils , Oxidation-Reduction , Peru , Sulfates/metabolism
4.
J Neurol Neurosurg Psychiatry ; 76(11): 1585-7, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16227558

ABSTRACT

BACKGROUND: Homocysteine may be involved in the pathogenesis of late onset Alzheimer's disease. It is implicated in the metabolism of several important pathways in the brain. Methylmalonic acid (MMA) is related to the metabolism of branched chained amino acids and fatty acids. OBJECTIVES: To compare cerebrospinal fluid (CSF) total homocysteine and MMA in elderly subjects, patients with Alzheimer's disease, and younger healthy controls. SUBJECTS: CSF samples were obtained from 33 patients under 20 years of age; 28 patients aged 21 to 60 years; 22 normal elderly subjects aged over 60; and 38 Alzheimer patients aged over 60. RESULTS: CSF total homocysteine increased with age (mean (SD): 57 (35) nmol/l in the youngest group v 123 (89) nmol/l in the elderly group (p<0.001)). There was no difference between the elderly group and Alzheimer patients (115 (62) nmol/l). CSF MMA did not differ in the elderly group and the Alzheimer group (38 (13) v 35 (14) ng/ml). In the youngest group, it was significantly higher (60 (15) ng/ml). CONCLUSIONS: CSF total homocysteine is not increased in Alzheimer's disease compared with age matched controls. CSF total homocysteine was correlated with age. The decrease in CSF MMA levels with age eliminates a lack of vitamin B-12 at neuronal level.


Subject(s)
Alzheimer Disease/cerebrospinal fluid , Alzheimer Disease/physiopathology , Homocysteine/cerebrospinal fluid , Methylmalonic Acid/cerebrospinal fluid , Adult , Aged , Female , Humans , Male , Middle Aged
5.
J Neural Transm (Vienna) ; 111(4): 547-67, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15057524

ABSTRACT

Hyperhomocysteinemia is common in Alzheimer's disease and is negatively correlated with cognitive function. Hyperhomocysteinemia can increase S-adenosylhomocysteine (SAH), a potent methyltransferase inhibitor. This study investigates the role of brain SAH in the cognitive and neurological disruption in Alzheimer's disease. SAH was significantly (26%) higher in prefrontal cortex of Alzheimer patients than normals. Brain homogenates from Alzheimer patients inhibited an exogenous methyltransferase 15% more than normal homogenates (P <.001). Brain SAH levels correlated (r=.508) with methyltransferase inhibition by brain homogenates. Methyltransferase inhibition by Alzheimer brain homogenates correlated inversely with cognitive function as determined by MMSE (r=-0.36). Phenylethanolamine N-methyltransferase (PNMT) and catechol O-methyltransferase (COMT) activities were more than 30% lower (P<0.001) in Alzheimer than normal brains. Brain PNMT activity correlated significantly with cognitive function (r=0.243), age of Alzheimer's onset (r=0.272), and choline acetyltransferase activity (r=0.333), but negatively with neurofibrillary tangles (r=-0.332). COMT activity also correlated significantly with cognitive function (r=0.324), age of disease onset (r=0.209), choline acetyltransferase activity (r=0.326), levels of synaptophysin (r=0.506), and negatively with tangles (r=-0.216 P=0.039). Elevated SAH in Alzheimer brain inhibits methyltransferases and is related to markers of disease progression and cognitive impairment.


Subject(s)
Alzheimer Disease/metabolism , Brain/metabolism , Brain/pathology , Cognition , Methyltransferases/metabolism , S-Adenosylhomocysteine/metabolism , Adult , Aged , Aged, 80 and over , Alzheimer Disease/psychology , Female , Humans , Hyperhomocysteinemia/metabolism , Male , Middle Aged , Neurofibrillary Tangles/pathology , Prefrontal Cortex/metabolism , Prefrontal Cortex/pathology , Time Factors
6.
Mech Ageing Dev ; 122(16): 2013-23, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11589919

ABSTRACT

Hyperhomocysteinemia is a known risk factor for vascular disease and commonly occurs in the elderly. Several studies have shown an association between elevated plasma homocysteine levels and cognitive impairment, indicating that it may play a role in the pathophysiology of dementia. We studied plasma homocysteine, folate, vitamin B12 levels and the MTHFR C677T genotype in an Italian population of patients with dementia. We confirmed that elevated plasma tHcy (>14 micromol/l) is common in elderly subjects with dementia. Although we found a high prevalence of the MTHFR TT genotype (21.2%) the allele frequency is not over-represented relative to the control population. We also observed a high incidence of folate deficiency (38%) in subjects with dementia. Elevated homocysteine was associated with low plasma folate (<5.7 nmol/l) and the MTHFR TT genotype. Moderate to severe hyperhomocysteinemia (>26.1 nmol/l) was associated with a significantly lower MMSE score. Hyperhomocysteinemia may be neurotoxic by several different mechanisms affecting cognitive function. Further studies are needed to fully explore the potential of B vitamin supplementation to lower plasma homocysteine and improve cognitive function.


Subject(s)
Dementia/enzymology , Homocysteine/blood , Oxidoreductases Acting on CH-NH Group Donors/genetics , Point Mutation , Aged , Alanine/genetics , Alanine/metabolism , Dementia/blood , Dementia/genetics , Dementia/metabolism , Female , Folic Acid/blood , Humans , Italy , Male , Methylenetetrahydrofolate Reductase (NADPH2) , Oxidoreductases Acting on CH-NH Group Donors/metabolism , Valine/genetics , Valine/metabolism , Vitamin B 12/blood
7.
Circ Res ; 88(11): 1203-9, 2001 Jun 08.
Article in English | MEDLINE | ID: mdl-11397788

ABSTRACT

Hyperhomocysteinemia is associated with increased risk for cardiovascular events, but it is not certain whether it is a mediator of vascular dysfunction or a marker for another risk factor. Homocysteine levels are regulated by folate bioavailability and also by the methyl donor S-adenosylmethionine (SAM) and its metabolite S-adenosylhomocysteine (SAH). We tested the hypotheses that endothelial dysfunction occurs in hyperhomocysteinemic mice in the absence of folate deficiency and that levels of SAM and SAH are altered in mice with dysfunction. Heterozygous cystathionine beta-synthase-deficient (CBS(+/-)) and wild-type (CBS(+/+)) mice were fed a folate-replete, methionine-enriched diet. Plasma levels of total homocysteine were elevated in CBS(+/-) mice compared with CBS(+/+) mice after 7 weeks (27.1+/-5.2 versus 8.8+/-1.1 micromol/L; P<0.001) and 15 weeks (23.9+/-3.0 versus 13.0+/-2.3 micromol/L; P<0.01). After 15 weeks, but not 7 weeks, relaxation of aortic rings to acetylcholine was selectively impaired by 35% (P<0.05) and thrombomodulin anticoagulant activity was decreased by 20% (P<0.05) in CBS(+/-) mice. Plasma levels of folate did not differ between groups. Levels of SAH were elevated approximately 2-fold in liver and brain of CBS(+/-) mice, and correlations were observed between plasma total homocysteine and SAH in liver (r=0.54; P<0.001) and brain (r=0.67; P<0.001). These results indicate that endothelial dysfunction occurs in hyperhomocysteinemic mice even in the absence of folate deficiency. Endothelial dysfunction in CBS(+/-) mice was associated with increased tissue levels of SAH, which suggests that altered SAM-dependent methylation may contribute to vascular dysfunction in hyperhomocysteinemia.


Subject(s)
Cystathionine beta-Synthase/deficiency , Endothelium, Vascular/physiopathology , Hyperhomocysteinemia/physiopathology , S-Adenosylhomocysteine/metabolism , Animals , Aorta/drug effects , Aorta/metabolism , Aorta/physiopathology , Brain/metabolism , Chronic Disease , Cystathionine beta-Synthase/genetics , Disease Models, Animal , Folic Acid/blood , Food, Fortified , Heterozygote , Homocysteine/blood , Hyperhomocysteinemia/blood , In Vitro Techniques , Liver/metabolism , Methionine/blood , Methylation , Mice , Mice, Inbred C57BL , Mice, Knockout , S-Adenosylmethionine/metabolism , Thrombomodulin/metabolism , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology , Vasomotor System/drug effects , Vasomotor System/physiopathology
8.
Stroke ; 32(3): 714-8, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11239192

ABSTRACT

BACKGROUND AND PURPOSE: The pathogenesis of cervical artery dissection (CAD) remains unknown in most cases. Hyperhomocyst(e)inemia [hyperH(e)], an independent risk factor for cerebrovascular disease, induces damage in endothelial cells in animal cell culture. Consecutive patients with CAD and age-matched control subjects have been studied by serum levels of homocyst(e)ine and the genotype of 5,10-methylenetetrahydrofolate reductase (MTHFR). METHODS: Twenty-six patients with CAD, admitted to our Stroke Unit (15 men and 11 women; 16 vertebral arteries, 10 internal carotid arteries), were compared with age-matched control subjects. All patients underwent duplex ultrasound, MR angiography, and/or conventional angiography. RESULTS: Mean plasma homocyst(e)ine level was 17.88 micromol/L (range 5.95 to 40.0 micromol/L) for patients with CAD and 6.0+/-0.99 micromol/L for controls (P:<0.001). The genetic analysis for the thermolabile form of MTHFR in CAD patients showed heterozygosity in 54% and homozygosity in 27%; comparable figures for controls were 40% (P:=0.4) and 10% (P:=0.1), respectively. CONCLUSIONS: Mild hyperH(e) might represent a risk factor for cervical artery dissection. The MTHFR mutation is not significantly associated with CAD. An interaction between different genetic and environmental factors probably takes place in the cascade of pathogenetic events leading to arterial wall damage.


Subject(s)
Carotid Artery, Internal, Dissection/diagnosis , Hyperhomocysteinemia/diagnosis , Vertebral Artery Dissection/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Angiography , Carotid Artery, Internal, Dissection/blood , Carotid Artery, Internal, Dissection/epidemiology , Comorbidity , Disease Susceptibility , Female , Folic Acid/blood , Genotype , Homocysteine/blood , Homocystine/blood , Humans , Hyperhomocysteinemia/blood , Hyperhomocysteinemia/epidemiology , Hyperhomocysteinemia/genetics , Male , Methylenetetrahydrofolate Reductase (NADPH2) , Middle Aged , Oxidoreductases Acting on CH-NH Group Donors/genetics , Risk Factors , Vertebral Artery Dissection/blood , Vertebral Artery Dissection/epidemiology , Vitamin B 12/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...